In a study of breast cancer, high expression of E2F4 was observed; such abnormal expression was also associated with TNM staging11, which suggests that E2F4 may play a tumor-promoting role in HNSCC, similar to in breast, gastric and prostate cancers. The gene discussed is E2F4; the disease is prostate carcinoma.